Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 24470498000
SciProfiles: 1015046

Activities

Collapse all

Employment (2)

Charité - Universitätsmedizin Berlin: Berlin, DE

2022-01-01 to present | Senior Postdoc (Dermatology)
Employment
Source: Self-asserted source
Tobias Sinnberg

University of Tübingen: Tübingen, DE

2017-01-01 to present | laboratory head (Dermatology)
Employment
Source: Self-asserted source
Tobias Sinnberg

Works (50 of 85)

Items per page:
Page 1 of 2

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy.

Journal of Experimental & Clinical Cancer Research
2024 | Journal article | Author
DOI: 10.1186/s13046-023-02941-5
PMC: PMC10804659
PMID: 38263136
Part of ISSN: 0392-9078
Contributors: Meraz-Torres F; Niessner H; Plöger S; Riel S; Schörg B; Casadei N; Kneilling M; Schaller M; Flatz L; Macek B et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.

American Journal of Respiratory and Critical Care Medicine
2024 | Journal article
DOI: 10.1164/rccm.202311-2136OC
Part of ISSN: 1535-4970
Contributors: Wyss N; Berner F; Walter V; Jochum AK; Purde MT; Abdou MT; Sinnberg T; Hofmeister K; Pop OT; Hasan Ali O et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target

International Journal of Molecular Sciences
2024-11 | Journal article | Author
DOI: 10.3390/ijms252111853
Contributors: Matti Böcker; Eftychia Chatziioannou; Heike Niessner; Constanze Hirn; Christian Busch; Kristian Ikenberg; Hubert Kalbacher; Rupert Handgretinger; Tobias Sinnberg
Source: check_circle
Multidisciplinary Digital Publishing Institute

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils

Cancers
2024-05 | Journal article | Author
DOI: 10.3390/cancers16091767
Contributors: Simone Wendlinger; Jonas Wohlfarth; Claudia Siedel; Sophia Kreft; Teresa Kilian; Sarah Junker; Luisa Schmid; Tobias Sinnberg; Ulrich Dischinger; Markus V Heppt et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x<sub>L</sub>/Bcl-w Inhibitors

International Journal of Molecular Sciences
2024-03 | Journal article | Author
DOI: 10.3390/ijms25063453
Contributors: Zhe Peng; Bernhard Gillissen; Antje Richter; Tobias Sinnberg; Max S. Schlaak; Jürgen Eberle
Source: check_circle
Multidisciplinary Digital Publishing Institute

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.

Journal of Autoimmunity
2023 | Journal article
DOI: 10.1016/j.jaut.2023.103118
PMID: 37826919
Part of ISSN: 0896-8411
Contributors: Lichtensteiger C; Koblischke M; Berner F; Jochum AK; Sinnberg T; Balciunaite B; Purde MT; Walter V; Abdou MT; Hofmeister K et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.

EBioMedicine
2023 | Journal article
DOI: 10.1016/j.ebiom.2023.104644
PMID: 37295047
Part of ISSN: 2352-3964
Contributors: Chatziioannou E; Roßner J; Aung TN; Rimm DL; Niessner H; Keim U; Serna-Higuita LM; Bonzheim I; Kuhn Cuellar L; Westphal D et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy.

Journal of the American Academy of Dermatology
2023 | Journal article
DOI: 10.1016/j.jaad.2023.06.057
PMID: 37487833
Part of ISSN: 1097-6787
Contributors: Amaral T; Pop OT; Chatziioannou E; Sinnberg T; Niessner H; Zhao J; Ring SS; Joerger M; Schroeder C; Armeanu-Ebinger S et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins.

International Journal of Molecular Sciences
2023 | Journal article
DOI: 10.3390/ijms24054961
PMC: PMC10002974
PMID: 36902392
Part of ISSN: 1422-0067
Contributors: Peng Z; Bernhard Gillissen; Richter A; Sinnberg T; Schlaak MS; Jürgen Eberle
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy.

American Journal of Clinical Dermatology
2023 | Journal article
DOI: 10.1007/s40257-023-00775-7
PMC: PMC10195722
PMID: 37142875
Part of ISSN: 1175-0561
Contributors: Eftychia Chatziioannou; Leiter U; Thomas I; Keim U; Seeber O; Meiwes A; Boessenecker I; Gonzalez SS; Torres FM; Niessner H et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP).

European Journal of Cancer
2023 | Journal article
DOI: 10.1016/j.ejca.2022.12.021
PMID: 36739215
Part of ISSN: 1879-0852
Contributors: Amaral T; Sinnberg T; Chatziioannou E; Niessner H; Leiter U; Keim U; Forschner A; Dwarkasing J; Tjien-Fooh F; Wever R et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.

Journal of Experimental & Clinical Cancer Research
2023 | Journal article
DOI: 10.1186/s13046-023-02755-5
PMC: PMC10354913
PMID: 37464364
Part of ISSN: 0392-9078
Contributors: Corinna Kosnopfel; Wendlinger S; Niessner H; Siewert J; Sinnberg T; Hofmann A; Wohlfarth J; Schrama D; Berthold M; Siedel C et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction In Vitro and In Vivo.

Cancer Research Communications
2023 | Journal article | Author
DOI: 10.1158/2767-9764.CRC-23-0101
PMC: PMC10478790
PMID: 37674529
Part of ISSN: 2767-9764
Contributors: Lisa Fröhlich; Heike Niessner; Birgit Sauer; Kämereit S; Eftychia Chatziioannou; Riel Simon; Tobias Sinnberg; Birgit Schittek
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.

American Journal of Respiratory and Critical Care Medicine
2023 | Journal article | Author
DOI: 10.1164/rccm.202201-0011OC
PMID: 35926164
Part of ISSN: 1535-4970
Contributors: Tobias Sinnberg; Lichtensteiger C; Omar Hasan Ali; Oltin-Tiberiu Pop; Ann-Kristin Jochum; Lorenz Risch; Silvio Daniel Brugger; Ana Velic; Bomze D; Philipp Kohler et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells.

Frontiers in Bioscience-Landmark
2023 | Journal article
DOI: 10.31083/j.fbl2809193
PMID: 37796710
Part of ISSN:

FRONT_BIOSCI-LANDMRK
Contributors: Speigl L; Janssen N; Weide B; Sinnberg T; Pawelec G; Shipp C
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Successful treatment of metastatic uveal melanoma with ipilimumab and nivolumab after severe progression under tebentafusp: a case report.

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2023.1167791
PMC: PMC10189013
PMID: 37207136
Part of ISSN: 2234-943X
Contributors: Reiter S; Schroeder C; Broche J; Sinnberg T; Bonzheim I; Süsskind D; Flatz L; Forschner A
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma

Cancers
2023-11 | Journal article | Author
DOI: 10.3390/cancers15235521
Contributors: Heike Niessner; Anna Hüsch; Corinna Kosnopfel; Matthias Meinhardt; Dana Westphal; Friedegund Meier; Bastian Schilling; Tobias Sinnberg
Source: check_circle
Multidisciplinary Digital Publishing Institute

High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma

Cells
2023-01 | Journal article | Author
DOI: 10.3390/cells12020254
Contributors: Markus Burkard; Heike Niessner; Christian Leischner; Alban Piotrowsky; Olga Renner; Luigi Marongiu; Ulrich M. Lauer; Christian Busch; Tobias Sinnberg; Sascha Venturelli
Source: check_circle
Multidisciplinary Digital Publishing Institute

[Melanoma-associated macrophages-from molecular signals to therapeutic application].

Dermatologie
2022 | Journal article
DOI: 10.1007/s00105-022-05077-3
PMID: 36394590
Part of ISSN: 2731-7013
Contributors: Chatziioannou E; Aydin SA; Forchhammer S; Sinnberg T; Eigentler T
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.

Science Immunology
2022 | Journal article
DOI: 10.1126/sciimmunol.abn9644
PMID: 36054337
Part of ISSN: 2470-9468
Contributors: Berner F; David Bomze; Christa Lichtensteiger; Walter V; Niederer R; Omar Hasan Ali; Wyss N; Jens Bauer; Lena Katharina Freudenmann; Ana Marcu et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Circulating tumor DNA (ctDNA) in the detection of relapse in melanoma patients with adjuvant anti-PD-1 therapy

JDDG - Journal of the German Society of Dermatology
2022 | Journal article
DOI: 10.1111/ddg.14766
EID:

2-s2.0-85129879640

Part of ISSN: 16100387 16100379
Contributors: Forschner, A.; Niessner, H.; Sinnberg, T.; Eigentler, T.; Amaral, T.; Seith, F.; Garbe, C.; Biskup, S.; Battke, F.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Enhanced expression of p21 promotes sensitivity of melanoma cells towards targeted therapies

Experimental Dermatology
2022 | Journal article
DOI: 10.1111/exd.14585
EID:

2-s2.0-85131068111

Part of ISSN: 16000625 09066705
Contributors: Fröhlich, L.M.; Makino, E.; Sinnberg, T.; Schittek, B.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms.

EBioMedicine
2022 | Journal article
DOI: 10.1016/j.ebiom.2022.104143
PMC: PMC9272337
PMID: 35810563
Part of ISSN: 2352-3964
Contributors: Aung TN; Shafi S; Wilmott JS; Nourmohammadi S; Vathiotis I; Gavrielatou N; Fernandez A; Yaghoobi V; Sinnberg T; Amaral T et al.
Source: check_circle
FACTScience - Charité Universitätsmedizin Berlin

Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression

International Journal of Molecular Sciences
2022-10 | Journal article | Author
DOI: 10.3390/ijms232012471
Contributors: Uly Sumarni; Jiaqi Zhu; Tobias Sinnberg; Jürgen Eberle
Source: check_circle
Multidisciplinary Digital Publishing Institute

Vitamin C Deficiency in Blood Samples of COVID-19 Patients

Antioxidants
2022-08 | Journal article | Author
DOI: 10.3390/antiox11081580
Contributors: Tobias Sinnberg; Christa Lichtensteiger; Katharina Hill-Mündel; Christian Leischner; Heike Niessner; Christian Busch; Olga Renner; Nina Wyss; Lukas Flatz; Ulrich Lauer et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo

Cells
2022-04 | Journal article | Author
DOI: 10.3390/cells11071229
Contributors: Heike Niessner; Markus Burkard; Christian Leischner; Olga Renner; Sarah Plöger; Francisco Meraz-Torres; Matti Böcker; Constanze Hirn; Ulrich M. Lauer; Sascha Venturelli et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Fetal Tissue-Derived Mast Cells (MC) as Experimental Surrogate for In Vivo Connective Tissue MC

Cells
2022-03 | Journal article | Author
DOI: 10.3390/cells11060928
Contributors: Caterina Iuliano; Magdalena Absmaier-Kijak; Tobias Sinnberg; Nils Hoffard; Miriam Hils; Martin Köberle; Florian Wölbing; Ekaterina Shumilina; Nicole Heise; Birgit Fehrenbacher et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

Frontiers in Oncology
2021 | Journal article
DOI: 10.3389/fonc.2021.643156
EID:

2-s2.0-85102600542

Part of ISSN: 2234943X
Contributors: Forschner, A.; Sinnberg, T.; Mroz, G.; Schroeder, C.; Reinert, C.P.; Gatidis, S.; Bitzer, M.; Eigentler, T.; Garbe, C.; Niessner, H. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

Journal for ImmunoTherapy of Cancer
2021 | Journal article
DOI: 10.1136/jitc-2021-003439
EID:

2-s2.0-85122391764

Part of ISSN: 20511426
Contributors: Bochem, J.; Zelba, H.; Spreuer, J.; Amaral, T.; Gaissler, A.; Pop, O.T.; Thiel, K.; Yurttas, C.; Soffel, D.; Forchhammer, S. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)

International Journal of Oncology
2021 | Journal article
DOI: 10.3892/IJO.2021.5215
EID:

2-s2.0-85105427901

Part of ISSN: 17912423 10196439
Contributors: RENNER, O.; BURKARD, M.; MICHELS, H.; VOLLBRACHT, C.; SINNBERG, T.; VENTURELLI, S.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Proteogenomics reveals perturbed signaling networks in malignant melanoma cells resistant to braf inhibition

Molecular and Cellular Proteomics
2021 | Journal article
DOI: 10.1016/j.mcpro.2021.100163
EID:

2-s2.0-85117888005

Part of ISSN: 15359484 15359476
Contributors: Schmitt, M.; Sinnberg, T.; Bratl, K.; Zittlau, K.; Garbe, C.; Macek, B.; Nalpas, N.C.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy

Cancers
2021-10 | Journal article | Author
DOI: 10.3390/cancers13215411
Contributors: Marisa Schmitt; Tobias Sinnberg; Heike Niessner; Andrea Forschner; Claus Garbe; Boris Macek; Nicolas Nalpas
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model

Nutrients
2021-07 | Journal article | Author
DOI: 10.3390/nu13072366
Contributors: Annie Lauer; Markus Burkard; Heike Niessner; Christian Leischner; Olga Renner; Claudia Vollbracht; Holger Michels; Christian Busch; Tobias Sinnberg; Sascha Venturelli
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery - The BUMPER study

Neuro-Oncology Advances
2020 | Journal article
DOI: 10.1093/noajnl/vdaa140
EID:

2-s2.0-85105501082

Part of ISSN: 26322498
Contributors: Amaral, T.; Niessner, H.; Sinnberg, T.; Thomas, I.; Meiwes, A.; Garbe, C.; Garzarolli, M.; Rauschenberg, R.; Eigentler, T.; Meier, F.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours

Nature Communications
2020 | Journal article
DOI: 10.1038/s41467-020-14987-6
EID:

2-s2.0-85081715323

Part of ISSN: 20411723
Contributors: Brenner, E.; Schörg, B.F.; Ahmetlić, F.; Wieder, T.; Hilke, F.J.; Simon, N.; Schroeder, C.; Demidov, G.; Riedel, T.; Fehrenbacher, B. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Circulating tumor DNA correlates with outcome in metastatic melanoma treated by braf and mek inhibitors – results of a prospective biomarker study

OncoTargets and Therapy
2020 | Journal article
DOI: 10.2147/OTT.S248237
EID:

2-s2.0-85086044338

Part of ISSN: 11786930
Contributors: Forschner, A.; Weißgraeber, S.; Hadaschik, D.; Schulze, M.; Kopp, M.; Kelkenberg, S.; Sinnberg, T.; Garbe, C.; Biskup, S.; Battke, F.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma

European Journal of Cancer
2020 | Journal article
DOI: 10.1016/j.ejca.2019.10.027
EID:

2-s2.0-85076185250

Part of ISSN: 18790852 09598049
Contributors: Amaral, T.M.S.; Hoffmann, M.-C.; Sinnberg, T.; Niessner, H.; Sülberg, H.; Eigentler, T.K.; Garbe, C.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors

American Journal of Pathology
2020 | Journal article
DOI: 10.1016/j.ajpath.2020.07.002
EID:

2-s2.0-85091218312

Part of ISSN: 15252191 00029440
Contributors: Gassenmaier, M.; Rentschler, M.; Fehrenbacher, B.; Eigentler, T.K.; Ikenberg, K.; Kosnopfel, C.; Sinnberg, T.; Niessner, H.; Bösmüller, H.; Wagner, N.B. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Individualised proteogenomics applied to analysis of amino acid variants in malignant melanoma

bioRxiv
2020 | Other
DOI: 10.1101/2020.12.15.422879
EID:

2-s2.0-85099900433

Part of ISSN: 26928205
Contributors: Schmitt, M.; Sinnberg, T.; Bratl, K.; Garbe, C.; Macek, B.; Nalpas, N.C.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

MDM2, MDM4 and EGFR amplifications and hyperprogression in metastatic acral and mucosal melanoma

Cancers
2020 | Journal article
DOI: 10.3390/cancers12030540
EID:

2-s2.0-85079905034

Part of ISSN: 20726694
Contributors: Forschner, A.; Hilke, F.-J.; Bonzheim, I.; Gschwind, A.; Demidov, G.; Amaral, T.; Ossowski, S.; Riess, O.; Schroeder, C.; Martus, P. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition

Cell Death and Disease
2020 | Journal article
DOI: 10.1038/s41419-020-2702-y
EID:

2-s2.0-85088586781

Part of ISSN: 20414889
Contributors: Makino, E.; Fröhlich, L.M.; Sinnberg, T.; Kosnopfel, C.; Sauer, B.; Garbe, C.; Schittek, B.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?

Cancers
2020-11 | Journal article | Author
DOI: 10.3390/cancers12123538
Contributors: Francisco Meraz-Torres; Sarah Plöger; Claus Garbe; Heike Niessner; Tobias Sinnberg
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

Cancers
2020-08 | Journal article | Author
DOI: 10.3390/cancers12092359
Contributors: Franz Joachim Hilke; Tobias Sinnberg; Axel Gschwind; Heike Niessner; German Demidov; Teresa Amaral; Stephan Ossowski; Irina Bonzheim; Martin Röcken; Olaf Riess et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion

Cancers
2020-08 | Journal article | Author
DOI: 10.3390/cancers12082328
Contributors: Corinna Kosnopfel; Tobias Sinnberg; Birgit Sauer; Heike Niessner; Alina Muenchow; Birgit Fehrenbacher; Martin Schaller; Peter R. Mertens; Claus Garbe; Basant Kumar Thakur et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Cancers
2020-04 | Journal article | Author
DOI: 10.3390/cancers12051101
Contributors: Teresa Amaral; Martin Schulze; Tobias Sinnberg; Maike Nieser; Peter Martus; Florian Battke; Claus Garbe; Saskia Biskup; Andrea Forschner
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: A single-center experience

Medicine (United States)
2019 | Journal article
DOI: 10.1097/MD.0000000000017348
EID:

2-s2.0-85072990489

Part of ISSN: 15365964 00257974
Contributors: Kaur, A.; Doberstein, T.; Amberker, R.R.; Garje, R.; Field, E.H.; Singh, N.; Sinnberg, T.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Quantitative proteomics links the intermediate filament nestin to resistance to targeted BRAF inhibition in melanoma cells

Molecular and Cellular Proteomics
2019 | Journal article
DOI: 10.1074/mcp.RA119.001302
EID:

2-s2.0-85066501887

Part of ISSN: 15359484 15359476
Contributors: Schmitt, M.; Sinnberg, T.; Nalpas, N.C.; Maass, A.; Schittek, B.; Macek, B.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Targeting tumor-resident mast cells for effective anti-melanoma immune responses

JCI Insight
2019 | Journal article
DOI: 10.1172/jci.insight.125057
EID:

2-s2.0-85072984168

Part of ISSN: 23793708
Contributors: Kaesler, S.; Wölbing, F.; Kempf, W.E.; Skabytska, Y.; Köberle, M.; Volz, T.; Sinnberg, T.; Amaral, T.; Möckel, S.; Yazdi, A. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - Results of a prospective biomarker study

Journal for ImmunoTherapy of Cancer
2019 | Journal article
DOI: 10.1186/s40425-019-0659-0
EID:

2-s2.0-85068916315

Part of ISSN: 20511426
Contributors: Forschner, A.; Battke, F.; Hadaschik, D.; Schulze, M.; Weißgraeber, S.; Han, C.-T.; Kopp, M.; Frick, M.; Klumpp, B.; Tietze, N. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier

6- and 8-Prenylnaringenin, novel natural histone deacetylase inhibitors found in hops, exert antitumor activity on melanoma cells

Cellular Physiology and Biochemistry
2018 | Journal article
DOI: 10.1159/000495275
EID:

2-s2.0-85057078734

Part of ISSN: 14219778 10158987
Contributors: Venturelli, S.; Niessner, H.; Sinnberg, T.; Berger, A.; Burkard, M.; Urmann, C.; Donaubauer, K.; Böcker, A.; Leischner, C.; Riepl, H. et al.
Source: Self-asserted source
Tobias Sinnberg via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (9 reviews for 7 publications/grants)

Review activity for BMC cancer (2)
Review activity for British journal of cancer. (2)
Review activity for Cancers. (1)
Review activity for EMBO journal. (1)
Review activity for Medicina. (1)
Review activity for Nature communications (1)
Review activity for Oncogene. (1)
How many people are using ORCID?